Publication
Article
BioPharm International
BioPharm International, Regulatory Sourcebook October 2021Volume2021 eBook Issue 4
Pages: 30-33
Industry Organizations Assist Pharma During the Pandemic and Beyond
Author(s):
BioPharm International checked in with AAPS, IPEC-Americas, and PDA to get an update on how the organizations are navigating the pandemic and planning for the future.
leowolfert - Stock.adobe.com
Pharmaceutical development, manufacturing, and quality efforts are often advanced by the work of industry associations and members through conferences, training sessions, publications, and working groups. These efforts continued during the past 18 months, despite restrictions posed by the COVID-19 pandemic. The American Association of Pharmaceutical Scientists (AAPS), the International Pharmaceutical Excipients Council of the Americas (IPEC-Americas), and the Parenteral Drug Association (PDA) shared recent activities and industry contributions with BioPharm International.
Read this article in BioPharm International’s October 2021 Regulatory Sourcebook eBook.
Article Details
BioPharm International
eBook: Regulatory Sourcebook eBook
October 2021
Pages: 30-33
Citation
When referring to this article, please cite it as BioPharm International Editors, "Industry Organizations Assist Pharma During the Pandemic and Beyond," BioPharm International Regulatory Sourcebook eBook, October 2021.
Articles in this issue
Industry Organizations Assist Pharma During the Pandemic and Beyond
NIST Proposes Clarifications to Bayh-Dole March-in Rights Regulations
How Artificial Intelligence Impacts the Global Regulatory Environment
Selecting the Right CMC Strategy for Biologics
The Evolving Biosimilar Approach
Serialization and Aggregation from a Manufacturing Perspective
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
